CYCLOPENTOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Cyclopentolate patents expire, and what generic alternatives are available?
Cyclopentolate is a drug marketed by Alcon Pharms Ltd, Sciegen Pharms, and Sola Barnes Hind. and is included in four NDAs.
The generic ingredient in CYCLOPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYCLOPENTOLATE?
- What are the global sales for CYCLOPENTOLATE?
- What is Average Wholesale Price for CYCLOPENTOLATE?
Summary for CYCLOPENTOLATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for CYCLOPENTOLATE |
| DailyMed Link: | CYCLOPENTOLATE at DailyMed |
US Patents and Regulatory Information for CYCLOPENTOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Pharms Ltd | CYCLOPENTOLATE HYDROCHLORIDE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 089162-001 | Jan 24, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Barnes Hind | CYCLOPENTOLATE HYDROCHLORIDE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084863-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sciegen Pharms | CYCLOPENTOLATE HYDROCHLORIDE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 205937-001 | Dec 9, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Barnes Hind | CYCLOPENTOLATE HYDROCHLORIDE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084150-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
